To specifically determine the functional consequence of inhibiting S100a4 in immune cells, we first deleted S100a4 from the host glioma microenvironment and orthotopically transplanted two independent syngeneic glioma tumorsphere cell lines (5459 and 2808). Here, S100A4 is linked to central nervous system cancer.